The federal Ready, Set, PrEP program ended July 2025. Many websites still list it as active. See what replaced it →
Access Guide

PrEP for Women in 2026: Which PrEP Works, How to Get It Free, and Pregnancy Safety

Published April 17, 2026 · 10 min read

Women make up roughly 18% of new HIV diagnoses in the U.S. each year — but only around 10% of people on PrEP are cisgender women. That gap exists because PrEP has historically been marketed to gay and bisexual men, and because most providers don't bring it up in women's health visits. This guide fixes that. Here's which PrEP options are FDA-approved for women, what's safe during pregnancy and breastfeeding, how to get it at $0, and how to talk to an OB-GYN or primary care provider about starting.

The short answer

If you're a cisgender woman (assigned female at birth) at risk of HIV — whether through a partner with HIV, a partner of unknown status, multiple partners, recent STI, needle sharing, or sexual assault — PrEP is for you, it's safe, and it should cost you $0. The main oral options that work for women are generic TDF/FTC (same as Truvada), and injectable options like Apretude and the new twice-yearly Yeztugo work for everyone. Descovy is not approved for people at risk through receptive vaginal sex — this is the one big exception.

~7,000 Women diagnosed with HIV in the U.S. each year
~10% Of PrEP users who are cisgender women
99%+ Effective when taken as prescribed
$0 What PrEP should cost you under the ACA

Which PrEP options are approved for women

Not every PrEP medication is FDA-approved for every route of HIV exposure. Here's what's approved for cisgender women:

Generic TDF/FTC (tenofovir disoproxil fumarate / emtricitabine)
Oral, daily. Same active ingredients as Truvada. ~$30/month cash retail.
Approved — women
Truvada (brand-name TDF/FTC)
Oral, daily. Identical to the generic. Rarely prescribed today because generic is so much cheaper.
Approved — women
Descovy (tenofovir alafenamide / emtricitabine)
Oral, daily. NOT approved for people at risk through receptive vaginal sex — clinical trials didn't include this population. Approved only for men and transgender women who have sex with men.
Not approved
Apretude (cabotegravir injectable)
Intramuscular injection every 2 months. Approved for adults at risk of HIV, including cisgender women.
Approved — women
Yeztugo (lenacapavir, twice-yearly injectable)
Subcutaneous injection every 6 months. In the PURPOSE 1 trial in cisgender women, zero participants on Yeztugo acquired HIV — the strongest trial result ever seen for any PrEP option.
Approved — women

Why Descovy isn't approved for women

Gilead never ran a Phase III trial of Descovy in cisgender women at risk through vaginal sex. Because the FDA approval rests on trial evidence, Descovy's label is limited to men and trans women who have sex with men. This is a regulatory gap, not a safety issue — the drug itself is safe for women — but prescribers should not use Descovy as PrEP for vaginal HIV exposure.

Is PrEP safe during pregnancy?

Yes. CDC, WHO, and ACOG (American College of Obstetricians and Gynecologists) all recommend PrEP during pregnancy for anyone at ongoing risk. Pregnancy actually increases HIV acquisition risk due to hormonal and immunological changes, and HIV acquired during pregnancy has a much higher risk of transmission to the baby — which is why PrEP becomes more important, not less.

The best-studied option during pregnancy is tenofovir/emtricitabine (generic TDF/FTC or Truvada), which has been used safely in hundreds of thousands of pregnancies for both HIV prevention and HIV treatment. Large registry studies show no increased risk of birth defects, preterm birth, or pregnancy complications.

Data on injectable PrEP (Apretude, Yeztugo) during pregnancy is more limited but growing. Most providers default to oral TDF/FTC during pregnancy because of the much larger safety database, though injectables may be considered case-by-case.

Is PrEP safe while breastfeeding?

Yes. Very small amounts of tenofovir and emtricitabine pass into breast milk, but infant exposure is minimal and no harmful effects have been documented. The CDC and WHO recommend continuing PrEP during breastfeeding if you're at risk of HIV.

This matters because the postpartum period is a high-risk window for HIV acquisition for some women, and breastfeeding with HIV can transmit the virus to the baby. Staying on PrEP protects both of you.

Get PrEP online, no OB-GYN visit required

MISTR prescribes PrEP to anyone at risk, including cisgender women, through a discreet telehealth visit. Medication, lab work, and consultations are $0 in all 50 states. Same-day or next-day prescription, shipped in unmarked packaging.

Use code: ANDR735

Using this code helps keep FreePrEP.org running and connects more people to free PrEP. It costs you nothing.

Start with MISTR →

PrEP and hormonal birth control

There are no known clinically significant interactions between PrEP and hormonal contraception. You can take PrEP with the pill, patch, ring, shot (Depo-Provera), implant (Nexplanon), or hormonal IUD without either one reducing the other's effectiveness. If your provider tells you otherwise, they may be confusing PrEP with HIV treatment regimens, some of which do interact with contraception.

PrEP does not protect against pregnancy — it only prevents HIV. If you want both HIV prevention and pregnancy prevention, you need PrEP plus a separate contraceptive method.

PrEP does not protect against other STIs

This is important. PrEP only prevents HIV — not chlamydia, gonorrhea, syphilis, herpes, HPV, or any other STI. If STI prevention matters to you (and for most women it should), there are two additional tools:

How to get PrEP as a woman

Option 1: Telehealth (fastest)

Specialized PrEP telehealth platforms like MISTR prescribe to anyone at risk, including cisgender women. No in-person visit, no OB-GYN appointment needed. They handle lab work and medication delivery at $0 in all 50 states for both insured and uninsured patients. This is typically the fastest path — same-day or next-day prescription.

Option 2: Planned Parenthood

Most Planned Parenthood health centers prescribe PrEP. Call ahead to confirm — not every location does, but most in major metro areas are well-equipped. Planned Parenthood has deep experience with women's sexual health and is often more comfortable territory than a men-focused LGBTQ+ clinic. Find a center at plannedparenthood.org or call 1-800-230-7526.

Option 3: Your OB-GYN or primary care provider

Any OB-GYN or primary care physician can prescribe PrEP — they don't need to be an infectious disease specialist. If yours isn't familiar with PrEP, you can ask them to consult the CDC's clinical guidelines (publicly available at cdc.gov/hiv/clinicians/prevention/prep.html). Every provider with prescribing authority can write a PrEP prescription.

Option 4: Community health centers (FQHCs)

Federally Qualified Health Centers offer PrEP on sliding-fee scales and serve everyone regardless of insurance or immigration status. Find one at findahealthcenter.hrsa.gov.

How to pay $0

Not sure where to start?

Use the eligibility tool — four questions, 60 seconds, no sign-up. We'll match you with every free PrEP program you qualify for.

Start the Eligibility Tool →

How to talk to a provider about PrEP

If it feels awkward to bring up, it's not just you. Most women's health providers don't proactively offer PrEP, and many patients feel nervous about initiating the conversation. A script that works well:

"I'd like to talk about PrEP — the medication that prevents HIV. I've been thinking about my risk factors and I'd like to start. Can we talk about which option would be right for me and order the baseline labs?"

That's it. You don't need to justify your request or disclose specific sexual practices unless you want to. "I'd like to start PrEP" is a complete sentence. Any provider who pushes back, dismisses you, or tries to talk you out of it is not a provider who's up to date on current CDC guidelines — find a different one.

What the baseline labs look like

Before starting PrEP, your provider will order a handful of tests: HIV test (you must be HIV-negative to start), hepatitis B test, kidney function test (creatinine), and often STI testing. Under the ACA, these are covered at $0. Telehealth platforms coordinate them through partner labs like Quest or LabCorp. Once you're on PrEP, you'll repeat these every 3 months.

Bottom line

PrEP for cisgender women is safe, effective, and available at $0 — the only reason uptake is so low is that it hasn't been properly marketed to women and most providers don't bring it up. If you're at risk and want protection, you have real options: daily oral generic PrEP, twice-yearly injectable Yeztugo, and every-two-months Apretude. Pregnancy and breastfeeding are not contraindications — they're often reasons to stay on PrEP. The main thing to remember is that Descovy isn't approved for vaginal sex exposure; everything else on the market is.

If you're ready to start, the fastest path is telehealth. If you prefer in-person care, Planned Parenthood, your OB-GYN, or a community health center all work.

Ready to start PrEP?

MISTR makes it straightforward — a short online intake, lab coordination, and medication shipped to your door at $0 in all 50 states. Designed for discretion and for people of every gender.

Use code: ANDR735

Using this code helps keep FreePrEP.org running and connects more people to free PrEP.

Get Started with MISTR →

Information sourced from CDC clinical guidelines, ACOG committee opinions, WHO recommendations, FDA prescribing labels, and peer-reviewed PURPOSE 1 trial publications. FreePrEP.org is an independent resource — not affiliated with any government agency or pharmaceutical company. Full disclosure